Understanding through experience.
Our Emerging Markets Center of Expertise enables us to stay abreast of the healthcare environment across key global markets and ensures we bring the breadth and depth of our experience and capabilities to our key account teams and clients.
Emerging markets offer exciting potential. However, these markets are uncertain, less understood, and constantly changing. With our expertise and experience, we help pharmaceutical companies succeed in these unchartered territories, by providing:
Together with local partners, we have on-the-ground local knowledge of multiple markets in key regions such as Asia-Pacific (APAC), including China and Japan, Latin America (LATAM), including Brazil, Middle East and North Africa (MENA), Sub-Saharan Africa and Central and Eastern Europe (CEE).
Our emerging markets team has considerable expertise in the ASEAN markets, with our Asia headquarters located in Singapore, and can support your market research needs. We have conducted over 175 healthcare market research projects across ASEAN covering a wide variety of research objectives and over 30 therapy areas, for both local and international organisations.
MENA is comprised of many countries in the North of Africa and Middle East including Algeria, Egypt, Israel, Kingdom of Saudi Arabia, South Africa and United Arab Emirates. Our emerging markets team has considerable expertise in MENA having conducted over 135 projects in 15 Middle Eastern and Northern African and can support you with your market research needs.
North Asia is comprised of China, Hong Kong, Japan, South Korea and Taiwan. With the exception of Hong Kong, the region’s healthcare systems are funded by the government and subsidised universally for their citizens offering coverage (to a varying extent) for in-patient service and ambulatory services. Our emerging markets team has conducted over 400 projects in the North Asian markets, with our Asia headquarters located in Singapore, and can support your market research needs.
As the various economies within Latin America and the Caribbean continue to grow, the healthcare market in these regions present a wide range of opportunities for the pharmaceutical industry. We know these markets and understand their complexities and characteristics. We have conducted over 500 healthcare market research projects across Latin America and the Caribbean covering a wide variety of research objectives and therapy areas.
Emerging Markets Your essential guide
Our interactive guide provides an overview of 10 key growth markets including Brazil, China and Saudi Arabia, covering key metrics, healthcare structure and policy, opportunity and demographics.
To find out more about our expertise, please contact us.
